Our current work, which incorporates the TWEAK-signaling pathway data into “NetPath”, would open avenues for further studies of TWEAK-associated proteins and related disorders, such as cancers and autoimmune diseases. This evidence concerns the gene TNFSF12 and autoimmune disease.